These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


245 related items for PubMed ID: 11391237

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
    Van Gool SW, Vermeiren J, Rafiq K, Lorr K, de Boer M, Ceuppens JL.
    Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
    [Abstract] [Full Text] [Related]

  • 3. Blockade of CD28-B7, but not CD40-CD154, prevents costimulation of allogeneic porcine and xenogeneic human anti-porcine T cell responses.
    Lee RS, Yamada K, Womer KL, Pillsbury EP, Allison KS, Marolewski AE, Geng D, Thall AD, Arn JS, Sachs DH, Sayegh MH, Madsen JC.
    J Immunol; 2000 Mar 15; 164(6):3434-44. PubMed ID: 10706740
    [Abstract] [Full Text] [Related]

  • 4. B7-CD28 interaction is a late acting co-stimulatory signal for human T cell responses.
    Zhang YQ, Joost van Neerven RJ, Van Gool SW, Coorevits L, de Boer M, Ceuppens JL.
    Int Immunol; 1997 Aug 15; 9(8):1095-102. PubMed ID: 9263006
    [Abstract] [Full Text] [Related]

  • 5. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J, Sakurai J, Saito K, Tani K, Asano S, Azuma M.
    Clin Exp Immunol; 2002 Jul 15; 129(1):61-8. PubMed ID: 12100023
    [Abstract] [Full Text] [Related]

  • 6. Human CD34(+) blood cells induce T-cell unresponsiveness to specific alloantigens only under costimulatory blockade.
    Arpinati M, Terragna C, Chirumbolo G, Rizzi S, Urbini B, Re F, Tura S, Baccarani M, Rondelli D.
    Exp Hematol; 2003 Jan 15; 31(1):31-8. PubMed ID: 12543104
    [Abstract] [Full Text] [Related]

  • 7. Activation of alloreactive T cells by allogeneic nonprofessional antigen-presenting cells and interleukin-12 from bystander autologous professional antigen-presenting cells.
    de Haan A, van der Gun I, van Dijk E, Hepkema BG, Prop J, de Leij LF.
    Transplantation; 2000 Apr 27; 69(8):1637-44. PubMed ID: 10836375
    [Abstract] [Full Text] [Related]

  • 8. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
    Koulova L, Clark EA, Shu G, Dupont B.
    J Exp Med; 1991 Mar 01; 173(3):759-62. PubMed ID: 1847724
    [Abstract] [Full Text] [Related]

  • 9. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
    Hayakawa Y, Takeda K, Yagita H, Van Kaer L, Saiki I, Okumura K.
    J Immunol; 2001 May 15; 166(10):6012-8. PubMed ID: 11342617
    [Abstract] [Full Text] [Related]

  • 10. Effects of immunoregulatory cytokines on the immunogenic potential of the cellular components of a bilayered living skin equivalent.
    Laning JC, DeLuca JE, Hardin-Young J.
    Tissue Eng; 1999 Apr 15; 5(2):171-81. PubMed ID: 10358223
    [Abstract] [Full Text] [Related]

  • 11. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
    Tan P, Anasetti C, Hansen JA, Melrose J, Brunvand M, Bradshaw J, Ledbetter JA, Linsley PS.
    J Exp Med; 1993 Jan 01; 177(1):165-73. PubMed ID: 7678111
    [Abstract] [Full Text] [Related]

  • 12. A T cell lymphoma can provide potent co-stimulatory effects to T cells that are not mediated by B7-1, B7-2, CD40, HSA or CD70.
    Nieland JD, Kruisbeek AM.
    Int Immunol; 1995 Nov 01; 7(11):1827-38. PubMed ID: 8580081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Costimulatory blockade of CD154-CD40 in combination with T-cell lymphodepletion results in prevention of allogeneic sensitization.
    Xu H, Yan J, Huang Y, Chilton PM, Ding C, Schanie CL, Wang L, Ildstad ST.
    Blood; 2008 Mar 15; 111(6):3266-75. PubMed ID: 17827394
    [Abstract] [Full Text] [Related]

  • 15. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T cells towards soluble recall antigens.
    Yi-qun Z, Joost van Neerven RJ, Kasran A, de Boer M, Ceuppens JL.
    Int Immunol; 1996 Jan 15; 8(1):37-44. PubMed ID: 8671587
    [Abstract] [Full Text] [Related]

  • 16. Blockade of multiple costimulatory receptors induces hyporesponsiveness: inhibition of CD2 plus CD28 pathways.
    Woodward JE, Qin L, Chavin KD, Lin J, Tono T, Ding Y, Linsley PS, Bromberg JS, Baliga P.
    Transplantation; 1996 Oct 15; 62(7):1011-8. PubMed ID: 8878397
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Costimulation of CD28- T lymphocytes by 4-1BB ligand.
    DeBenedette MA, Shahinian A, Mak TW, Watts TH.
    J Immunol; 1997 Jan 15; 158(2):551-9. PubMed ID: 8992967
    [Abstract] [Full Text] [Related]

  • 19. Alloantigen-specific T-cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact.
    Otten HG, Bor B, Ververs C, Verdonck LF, De Boer M, De Gast GC.
    Immunology; 1996 Jun 15; 88(2):214-9. PubMed ID: 8690453
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P, Liu Z, Wu C, Zhu B, Wang Y, Xu H.
    Transplant Proc; 2008 Oct 15; 40(8):2729-33. PubMed ID: 18929847
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.